Markets:

Overview

News

Currencies

International

Treasuries

Bayer Aktienges ADR (OP:BAYRY)

9.670 UNCHANGED

Streaming Delayed Price Updated: 3:59 PM EST, Dec 5, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bayer Aktienges ADR

< Previous 1 2 3 4 5 6 7 8 Next >

The Journey To Rewrite Human DNA Is About To Get Wild, Thanks To Pfizer, Bayer, Intellia And Other CRISPR stocks ↗

January 13, 2022

Big Pharma is paying attention to CRISPR stocks. Could that alight shares this year?

Via Investor's Business Daily

Biotech Bloodbath Continues Despite Gene-Editing Deals For Pfizer, Bayer ↗

January 10, 2022

Pfizer and Bayer inked deals with several companies in gene-editing.

Via Investor's Business Daily

Corporate Cannabis Takeover? Assessing 5 Big Industries Already At The Table ↗

December 23, 2021

This article was originally published on The Bluntness, and ...

Via Benzinga

Recursion, Bayer Expand Fibrosis Pact To Include Inferential Search Capabilities ↗

December 06, 2021

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) expanded its existing strategic collaboration in fibrosis with Bayer AG (OTC: BAYRY). The expanded...

Via Benzinga

The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO ↗

August 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

Even Good Penny Stocks Like Senseonics Aren’t Always Profitable ↗

December 03, 2021

Its latest implanted sensor lasts six months, but SENS stock faces competition from Dexcom, Abbott Labs and potentially one big name in tech.

Via InvestorPlace

Bayer's Nubeqa Shows Prolonged Survival In Late-Stage Prostate Cancer Trial ↗

December 03, 2021

Bayer AG (OTC: BAYRY) said a combination therapy, including its Nubeqa drug, was shown to prolong the lives of men who have metastatic prostate cancer in a clinical...

Via Benzinga

Microsoft, Bayer Collaborate To Develop Digital Agricultural Tools, Capabilities ↗

November 17, 2021

Microsoft Corp (NASDAQ: MSFT) and Bayer AG (OTC: BAYRY) (OTC: BAYZF) collaborated on new internet-based products aimed at helping farmers and industries...

Via Benzinga

The Secret To Successful Investing In Biotech ↗

October 19, 2021

Have you ever had a stock jump 30%, 50% or 100% in one day?

Via Talk Markets

Agricultural Technology Companies Are Finding Themselves in a Global Race to Develop and Acquire New Intellectual Property ↗

October 18, 2021

Image by AgriFORCE The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga...

Via Benzinga

The Daily Biotech Pulse: Moderna's Booster Shot Gets FDA Panel Backing, Decision Day For Avadel, Silence Therapeutics Strikes Licensing Deal, MiNK IPO ↗

October 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Adcom Recommends Approval Of Moderna's COVID-19 Vaccine Booster Shot For...

Via Benzinga

Here’s What Happens When You Beat The Market By 5% (And How To Do It) ↗

October 11, 2021

See, the way Wall Street makes money has fundamentally shifted in recent years. So has the way information flows to individual investors. And today I want to show you how savvy stock pickers can profit...

Via Talk Markets

I See Another “Chipotle Moment” ↗

September 27, 2021

Lawsuits are terrible for business. They bring distractions, extra costs, and uncertainty. Big Tobacco knows this all too well.

Via Talk Markets

Topics Lawsuit

Acceleron Stock Heats Up On $11 Billion Takeover Rumor; So, Who's The Buyer? ↗

September 27, 2021

A biotech working in lung and blood diseases, as well as cancer, could be acquired.

Via Investor's Business Daily

BWXT Medical, Bayer AG Ink Agreement On Actinium-225 ↗

September 16, 2021

BWX Technologies Inc's (NYSE: BWXT) subsidiary BWXT Medical Ltd. has agreed with Bayer AG (OTC: BAYRY) to develop Actinium-225 (Ac-225) supply and...

Via Benzinga

Regeneron Touts Mid-Stage Win For Higher Dose Of Eylea In Age-related Macular Degeneration ↗

August 24, 2021

Regeneron Pharmaceuticals Inc (NASDAQ: REGN) revealed new Phase 2 proof-of-concept trial data on Eylea (aflibercept) injection in patients with wet age-related...

Via Benzinga

Berkeley Lights, Bayer Ink Discovery Pact For Next-Gen Traits In Agricultural Sector, Berkeley Q2 Earnings Miss Estimates ↗

August 11, 2021

Berkeley Lights Inc (NASDAQ: BLI) reports Q2 sales of $19.3 million, +82% Y/Y, but slightly missing the consensus of $19.64 million. The Company expanded the installed...

Via Benzinga

Topics Earnings

3 Pharma Stocks to Buy in August ↗

August 11, 2021

These stocks offer solid growth opportunities.

Via The Motley Fool

Bristol Myers Pulls Accelerated Approval For Opdivo In Post-Nexavar Liver Cancer ↗

July 26, 2021

Bristol Myers Squibb & Co (NYSE: BMY) on Friday said it's voluntarily withdrawing Opdivo's approval in hepatocellular carcinoma (HCC) patients who...

Via Benzinga

The Cloud Sector Can Drive Your Profits Sky High ↗

July 21, 2021

If you hear someone suggesting you invest in “containers,” please don’t get confused. Most folks would naturally think of these as giant metal shipping boxes that are integral for global trade.

Via Talk Markets

Merck - Bayer's Heart Failure Treatment, Verquvo Scores European Nod ↗

July 21, 2021

The European Commission (EC) has approved Merck & Co Inc's (NYSE: MRK) soluble guanylate cyclase (sGC) stimulator Verquvo (vericiguat). Verquvo...

Via Benzinga

Bayer's Kerendia Scores Long-Awaited Kidney & Heart Disease Nod For Type 2 Diabetes ↗

July 12, 2021

The FDA on Friday approved Bayer AG's (OTC: BAYRY) chronic kidney disease (CKD) drug Kerendia (finerenone), the first and only nonsteroidal mineralocorticoid...

Via Benzinga

3 Top Biotech Stocks to Buy in July ↗

July 11, 2021

Now's the time to get into these companies while their valuation is still favorable.

Via The Motley Fool

3 Big Drugmakers to Buy Ahead of the Q2 Earnings Season ↗

July 10, 2021

The big drug companies are set for the second-quarter earnings season, which begins later this month.

Via Talk Markets

Cloud Stocks Change Name Of The Cloud Computing Game With 'Containers' From Amazon, Microsoft, Alphabet's Google ↗

July 02, 2021

Amazon, Microsoft and Google are promoting a model that may expand cloud computing.

Via Investor's Business Daily

Why Did Novocure Shares Plunge Today? ↗

July 01, 2021

Novocure Ltd (NASDAQ: NVCR) has announced final results from its phase 2 pilot HEPANOVA trial evaluating Tumor Treating Fields (TTFields) together with Bayer...

Via Benzinga

Exelixis Shares Drop On Mixed Results For Cabometyx Combo In Early Liver Cancer ↗

June 28, 2021

Exelixis Inc (NASDAQ: EXEL) and Ipsen (OTC: IPSEY) have announced mixed interim results from the COSMIC-312 Phase 3 trial evaluating cabozantinib (...

Via Benzinga

Bayer's Cell, Gene Therapies for Parkinson's Disease Enters Human Trials ↗

June 08, 2021

Bayer AG’s (OTC: BAYRY) Parkinson’s disease stem cell therapy has officially landed in the clinic, while another treatment for the neurodegenerative...

Via Benzinga

Bayer Buys Two Biotech Firms to Beef Up Radiopharmaceuticals ↗

June 03, 2021

Bayer AG (OTC: BAYRY) will acquire two small biotech companies in a deal that adds an experimental prostate cancer medicine to the German drugmaker's pipeline...

Via Benzinga

Bayer Mulls Ending US Retail Sales Of Weedkiller Glyphosate: Reuters ↗

May 27, 2021

A U.S. judge rejected Bayer AG’s (OTC: BAYRY) plan to try and limit the cost of future class action claims that its Roundup weedkiller causes cancer, saying that...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Bayer Aktienges ADR (OP:BAYRY)

All News about Bayer Aktienges ADR

Starting at $3.75/week.

Subscribe Today